I present my top 10 high-yield dividend stocks for July 2025, screened for strong yields, large market caps, and attractive ...

SCHD underperformed the S&P 500 in 2025 but remains highly attractive due to its strong risk-reward profile and dividend ...

Is Pfizer’s hefty 7% dividend yield safe? Undoubtedly, the name has encountered its fair share of pressures of late. And while the dividend is getting quite stretched, it’s not necessarily at ...

The highest dividend-paying stocks in the S&P 500 can be misleading. That's because, at first glance, these big dividends ...

A Wall Street maxim states, “Twenty percent of investors who want to make money are in stocks, while the other 80 percent who ...

There were 981 unusually active options in Wednesday trading. Of those, 597 were calls, and 384 were puts. Generally, I like ...

Pfizer Inc. (NYSE:PFE) is one of the Best Dividend Leaders to Buy Now. The company’s strategy focuses on steadily increasing its dividend, reinvesting in the business with strong financial ...

The company’s strategy focuses on steadily increasing its dividend, reinvesting in the business with strong financial returns, and carrying out value-driven share buybacks.

Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.43 third-quarter 2025 dividend on the company’s common stock, payable September 2, 2025, to holders of the ...

Pfizer (NYSE:PFE) recently announced positive topline results from its Phase 3 BASIS study for HYMPAVZI™ and declared a third-quarter 2025 dividend of $0.43 per share. Alongside these ...

Pfizer's built from many pieces that are moving in opposite directions. To make sure this stock isn't a yield trap destined to slash its dividend payout in the near term, let's weigh the good news ...

Pfizer faces a $1 billion sales hit in 2025 from IRA reforms, flat EPS and revenue forecasts, and long-term risks tied to patent expirations.